Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Massard

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Bulletin Du Cancer|November 2, 2010
[Cancer and the Internet: avoid being trapped in the web]S Vignot, C Massard
Bulletin Du Cancer|September 4, 2010
[Rare tumours: a new heading in Bulletin du cancer]C Massard, J-P Droz
Bulletin Du Cancer|July 28, 2010
[The Web: a help or a labyrinth for doctors?]C Demoor-Goldschmidt, C Massard
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2009
The quest for the 'bony Grail' of detecting circulating tumour cells in patients with prostate cancerC Massard, A Chauchereau, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2012
Recent developments in treatments targeting castration-resistant prostate cancer bone metastasesY Loriot, C Massard, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Tumour stem cell-targeted treatment: elimination or differentiationC Massard, E Deutsch, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?J C Soria, C Massard, T Le Chevalier
Bulletin Du Cancer|June 11, 2010
[Bladder cancer and new drugs]C Massard, B Albouy, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2008
Carcinomas of an unknown primary site: a curable disease?A Levy, C Massard, M Gross-Goupil, et al.
Bulletin Du Cancer|April 10, 2009
[Prognosis and predictive factors in prostate cancer]L Albiges-Sauvin, A Lévy, C Massard, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Bulletin Du Cancer|November 2, 2010
[Cancer and the Internet: avoid being trapped in the web]S Vignot, C Massard
Bulletin Du Cancer|September 4, 2010
[Rare tumours: a new heading in Bulletin du cancer]C Massard, J-P Droz
Bulletin Du Cancer|July 28, 2010
[The Web: a help or a labyrinth for doctors?]C Demoor-Goldschmidt, C Massard
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 13, 2009
The quest for the 'bony Grail' of detecting circulating tumour cells in patients with prostate cancerC Massard, A Chauchereau, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2012
Recent developments in treatments targeting castration-resistant prostate cancer bone metastasesY Loriot, C Massard, K Fizazi
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Tumour stem cell-targeted treatment: elimination or differentiationC Massard, E Deutsch, J-C Soria
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2010
Should progression-free survival be the primary measure of efficacy for advanced NSCLC therapy?J C Soria, C Massard, T Le Chevalier
Bulletin Du Cancer|June 11, 2010
[Bladder cancer and new drugs]C Massard, B Albouy, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 24, 2008
Carcinomas of an unknown primary site: a curable disease?A Levy, C Massard, M Gross-Goupil, et al.
Bulletin Du Cancer|April 10, 2009
[Prognosis and predictive factors in prostate cancer]L Albiges-Sauvin, A Lévy, C Massard, et al.
Pageof 9